Goldman Sachs Lifts Price Target On Alexion Pharmaceuticals (ALXN)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. SPCX
7. AVGO
8. RMAX
9. HD
10. BJ

September 26, 2011 3:53 PM EDT
Get Alerts ALXN Hot Sheet
Price: $182.01 --0%

Rating Summary:
    10 Buy, 25 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Earlier, Goldman Sachs raised its price target on Buy-rated Alexion Pharmaceuticals (NASDAQ: ALXN) from $68 to $72 after the company received FDA approval and a positive CHMPopinion for approval of Soliris in aHUS for both adults and pediatrics.

For more ratings news on Alexion Pharmaceuticals click here and for the rating history of Alexion Pharmaceuticals click here.

Shares of Alexion Pharmaceuticals closed at $66.15 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Goldman Sachs